The American Medical Association Opioid Task Force 2019 Progress Report shows Indiana's reduction in opioid prescriptions from 2013 to 2018 is two percentage points higher than the national average.
Array’s stock was already at a record before the deal announcement, following the company’s news last month of positive clinical trial results using Braftovi and Mektovi with Indianapolis-based Eli Lilly and Co.’s Erbitux.
Some of the biggest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., sued the Trump administration to try and block a rule that would force them to put the price of their drugs in television advertisements.
“Our central focus as a company is always to make lives better. … It’s a value that is core to every single employee who works here. So if we can have programs that reinforce that we are a company that is focused on making lives better, then we are doing something that connects to our mission and reminds our employees what really matters to us as a company.”
Across Indiana and the nation, hospitals are rolling out new programs to cut energy consumption and reduce their carbon footprints. In the process, they hope to save hundreds of thousands of dollars in the form of lower utility bills.
Nursing facilities have failed to report thousands of serious cases of potential neglect and abuse of seniors on Medicare even though it's a federal requirement for them to do so, according to a watchdog report released Wednesday.
The trials, which will begin in 2020, are part of a sweeping, five-year, $42 million federal research program known as Implementing Genomics in Practice. The first trial will examine whether early access to patients’ genomic data can help with treatment of high blood pressure, hypertension and chronic kidney disease.
The move comes as companies are turning to newer genetic engineering techniques that make it easier to tinker with the traits of plants and animals.
The organization, based on North Meridian Street, is changing its name to Versiti Blood Center of Indiana in a move designed to boost the identity of blood operations in five Midwest states.
As stand-up electric scooters have rolled into more than 100 cities worldwide, many of the people riding them are ending up in the emergency room with serious injuries. Others have been killed.
By clarifying terms such as “Sell by” and “Use by,” U.S. regulators are trying to prevent people from prematurely tossing products and to reduce the mountains of food that goes to waste each year.
Indianapolis-based Anthem said its purchase of Beacon Health Options fits with its strategy of diversifying into providing health care services, including for patients with complex and chronic conditions.
It’s the second approved use for Emgality, which first won U.S. approval last fall to treat migraines. Analysts predict it could become a blockbuster.
A federal judge grilled an attorney for the state of Indiana on Monday over whether the Legislature had legitimate reasons for approving a law that would largely ban a second-trimester abortion procedure.
After one of its largest listed drug makers was found to have overstated its cash position by $4.3 billion, China is starting an audit of 77 major pharmaceutical companies.
Hundreds of employees at the Corteva Agriscience Global Business Center in Indianapolis on Monday celebrated the official launch of the company and the first trading of its common stock.
The Indianapolis-based health system said the move will give patients more treatment options. It has opened five tiny hospitals in the last two years, and plans to open three more later this year.
The state’s largest abortion provider said it expects greater expenses for abortions because of the state law requiring burial or cremation of fetal remains upheld by the U.S. Supreme Court.
The medical field’s lofty dreams of unleashing the power of artificial intelligence to transform medicine have yet to materialize in a major way.
2019 Innovation Issue: Dr. Edward McGruder on improving pet health via the ‘internet of animal things’
Wearable devices have applications beyond people. We’re at a turning point in animal health where better data combined with innovative medicines is leading to better care for our pets.